|
|
Article: QIAGEN Extends Distribution Agreement With Abbott for QIAGEN's RealArt(TM) Molecular Diagnostic Tests.
- Article from:
- PR Newswire
- Article date:
- June 22, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
VENLO, The Netherlands, June 22 /PRNewswire-FirstCall/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) the world's leading provider of innovative enabling technologies and products for the separation, purification and handling of nucleic acids and proteins today announced that Abbott and QIAGEN have extended their existing distribution agreement. Under the terms of the agreement, Abbott received distribution rights to a number of real-time PCR diagnostic tests for use on Applied Biosystems detection instruments. The PCR assays were developed by artus GmbH, a company QIAGEN recently acquired.
Under the extended agreement Abbott has non-exclusive ...